Plato BioPharma Revenue and Competitors
Estimated Revenue & Valuation
- Plato BioPharma's estimated annual revenue is currently $1.4M per year.
- Plato BioPharma's estimated revenue per employee is $155,000
Employee Data
- Plato BioPharma has 9 Employees.
- Plato BioPharma grew their employee count by -25% last year.
Plato BioPharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & Founder | Reveal Email/Phone |
2 | Associate Scientist II | Reveal Email/Phone |
3 | Associate Scientist II | Reveal Email/Phone |
Plato BioPharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 11 | 0% | N/A | N/A |
#2 | $2.8M | 18 | 13% | N/A | N/A |
#3 | $70.2M | 453 | -1% | N/A | N/A |
#4 | $1.6M | 10 | -66% | N/A | N/A |
#5 | $3.7M | 24 | -8% | N/A | N/A |
#6 | $2.9M | 37 | 28% | N/A | N/A |
#7 | $3.1M | 20 | 25% | N/A | N/A |
#8 | $2.5M | 16 | -20% | N/A | N/A |
#9 | $9.1M | 59 | 0% | N/A | N/A |
#10 | $4.2M | 27 | -7% | N/A | N/A |
What Is Plato BioPharma?
Plato BioPharma, Inc. (PBI) offers an integrative approach to pre-clinical drug discovery in the cardiovascular, renal, pulmonary, and hepatic therapeutic areas. PBI's pre-clinical pharmacology platform begins with intricate in vivo models of disease followed by a systematic analysis of biomarkers, biochemicals and histology. This unified process provides our clients with constellations of data that aid to navigate the maze of drug discovery and development.
keywords:N/A
N/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Westminster
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.4M | 9 | 50% | N/A |
#2 | $1M | 9 | -10% | N/A |
#3 | $0.7M | 9 | N/A | N/A |
#4 | $0.9M | 10 | 0% | N/A |
#5 | $0.9M | 10 | 11% | N/A |